Clinical Outcomes of Metastatic Melanoma Treated With Checkpoint Inhibitors and Multisite Radiotherapy.
Where this comes from
- Record sourced from PubMed, PMID 28746710.
- Also identified by DOI 10.1001/jamadermatol.2017.2222 and PMC identifier 5817594.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines the treatment of patients with metastatic melanoma receiving multisite radiotherapy with in conjunction with immunotherapy.
Medical subject headings
- Ipilimumab
- Melanoma
- Radiotherapy, Conformal
- Skin
- Skin Neoplasms